Overview

Prevention of Corticosteroid-induced Glucose Intolerance

Status:
Unknown status
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
Glucose intolerance is frequent and serious complication of corticosteroid therapy. the aim of the study is to examine the hypothesis that co treatment with rosiglitazone can prevent glucose intolerance in patients treated with corticosteroids.
Phase:
Phase 3
Details
Lead Sponsor:
Hadassah Medical Organization
Treatments:
Rosiglitazone